Humana Stock in Focus

Large-cap Health Care company Humana has logged a 0.1% change today on a trading volume of 52,902. The average volume for the stock is 1,221,554.

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Based in Louisville, United States the company has 67,100 full time employees and a market cap of $62,221,139,968. Humana currently offers its equity investors a dividend that yields 0.7% per year.

The company is now trading -14.13% away from its average analyst target price of $584.79 per share. The 19 analysts following the stock have set target prices ranging from $468.0 to $640.0, and on average give Humana a rating of buy.

Over the last 52 weeks, HUM stock has risen 1.0%, which amounts to a -22.0% difference compared to the S&P 500. The stock's 52 week high is $571.3 whereas its 52 week low is $423.29 per share. With its net margins declining an average -8.1% over the last 6 years, Humana may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023-02-16 92,870,000 2,806,000 3 -25.0
2022-02-17 83,064,000 2,933,000 4 0.0
2021-02-18 77,155,000 3,367,000 4 0.0
2020-02-20 64,888,000 2,707,000 4 33.33
2019-02-21 56,912,000 1,683,000 3 -40.0
2018-02-16 53,767,000 2,448,000 5
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.